Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros










Intervalo de ano de publicação
1.
Biol Trace Elem Res ; 150(1-3): 342-9, 2012 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-23054862

RESUMO

Zinc is an element that under physiological conditions preferentially binds to and is a potent inducer of metallothionein under physiological conditions. The present study was conducted to explore whether zinc supplementation morphologically and biochemically protects against diabetic nephropathy through modulation of kidney metallothionein induction and oxidative stress in streptozotocin-induced diabetic rats. Thirty-two Wistar albino male rats were equally divided into four groups. The first group was used as untreated controls and the second group was supplemented with 30 mg/kg/day zinc as zinc sulfate. The third group was treated with streptozotocin to induce diabetes and the fourth group was treated with streptozotocin and supplemented with zinc as described for group 2. The blood glucose and micro-albuminuria levels, body and kidney weights were measured during the 42-day experimental period. At the end of the experiment, the kidneys were removed from all animals from the four groups. Diabetes resulted in degenerative kidney morphological changes. The metallothionein immunoreactivity level was lower and the kidney lipid peroxidation levels were higher in the diabetes group than in the controls. The metallothionein immunoreactivity levels were higher in the tubules of the zinc-supplemented diabetic rats as compared to the non-supplemented diabetic group. The zinc and metallothionein concentrations in kidney tissue were higher in the supplemented diabetic group compared to the non-supplemented diabetes group. The activity of glutathione peroxidase did not change in any of the four groups. In conclusion, the present study shows that zinc has a protective effect against diabetic damage of kidney tissue through stimulation of metallothionein synthesis and regulation of the oxidative stress.


Assuntos
Diabetes Mellitus Tipo 1/dietoterapia , Nefropatias Diabéticas/prevenção & controle , Suplementos Nutricionais , Rim/metabolismo , Metalotioneína/metabolismo , Estresse Oxidativo , Zinco/uso terapêutico , Animais , Antioxidantes/metabolismo , Antioxidantes/uso terapêutico , Diabetes Mellitus Tipo 1/complicações , Diabetes Mellitus Tipo 1/metabolismo , Diabetes Mellitus Tipo 1/patologia , Glutationa Peroxidase/metabolismo , Hipoglicemiantes/metabolismo , Hipoglicemiantes/uso terapêutico , Rim/patologia , Túbulos Renais/metabolismo , Túbulos Renais/patologia , Peroxidação de Lipídeos , Masculino , Metalotioneína/agonistas , Ratos , Ratos Wistar , Estreptozocina , Distribuição Tecidual , Regulação para Cima , Zinco/metabolismo , Sulfato de Zinco/administração & dosagem
4.
J Eur Acad Dermatol Venereol ; 13(3): 198-204, 1999 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-10642056

RESUMO

BACKGROUND: The development of squamous cell carcinomas is the main cause of death of patients with Dystrophic epidermolysis bullosa. We think it is of interest to know their clinical characteristics and the treatment difficulties they cause. METHODS: We followed the clinical evolutions and carried out histopathological studies of eight primary cutaneous squamous cell carcinomas on three males and one female with recessive dystrophic epidermolysis bullosa. Patient ages ranged from 16 to 34 years (mean 27). RESULTS: Two patients had two tumours and one three, all were in characteristically scarred skin; four on upper limbs; four on lower. Maximum tumour dimensions ranged from 2 to 28 cm (mean 13), and represented 6 or more months of evolution. In three cases the affected limb must be amputated. Five tumours were well differentiated, three were moderately differentiated. CONCLUSIONS: The patients consulted too late and their large lesions needed aggressive treatment. Appropriate information and regular examination of patients with RDEB helps early diagnosis of tumours and may avoid disabling operations.


Assuntos
Carcinoma de Células Escamosas/etiologia , Epidermólise Bolhosa Distrófica/complicações , Neoplasias Cutâneas/etiologia , Adolescente , Adulto , Carcinoma de Células Escamosas/patologia , Carcinoma de Células Escamosas/secundário , Causas de Morte , Cicatriz/patologia , Epidermólise Bolhosa Distrófica/genética , Feminino , Seguimentos , Genes Recessivos , Mãos , Humanos , Perna (Membro) , Metástase Linfática , Masculino , Recidiva Local de Neoplasia/patologia , Neoplasias Cutâneas/patologia
6.
Biol Trace Elem Res ; 34(2): 161-76, 1992 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-1381936

RESUMO

The lithium content of human hair shows an approximately linear response to extradietary lithium supplementation at dosage levels of up to 2000 micrograms/d. From the mean hair lithium concentration of 0.063 micrograms/g in 2648 predominantly American adults, and the reference hair lithium concentrations determined in the present study, the mean lithium intakes were calculated to be 730 micrograms/d. Hair lithium concentrations were extremely low in nearly 20% of the American samples, and in samples collected in Munich, Germany and Vienna, Austria. Hair lithium levels are low in certain pathological conditions, e.g., heart disease, in learning-disabled subjects, and in incarcerated violent criminals. The highest levels were observed in samples of a lithium-treated psychiatric patient. A statistically highly significant direct association was observed between the hair lithium and cobalt concentrations, which suggests a role of lithium in the transport and distribution of vitamin B12. Interactions of lithium with other trace elements are also discussed.


Assuntos
Cabelo/química , Lítio/análise , Oligoelementos/análise , Violência , Vitamina B 12/metabolismo , Adulto , Cobalto/análise , Cardiopatias/metabolismo , Humanos , Lítio/administração & dosagem , Manganês/análise , Transtornos Mentais/metabolismo , Couro Cabeludo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...